Toxicological Comparison of E2a-Deleted and First-Generation Adenoviral Vectors Expressingα1-Antitrypsin after Systemic Delivery-Reference-Cited by-同舟云学术

Toxicological Comparison of E2a-Deleted and First-Generation Adenoviral Vectors Expressingα1-Antitrypsin after Systemic Delivery

Published:1998-07-20 Issue:11 Volume:9 Page:1587-1598
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

O'Neal Wanda K.,Zhou Heshan,Morral Núria,Aguilar-Cordova Estuardo,Pestaner Joseph,Langston Claire,Mull Benjamin,Wang Yufen,Beaudet Arthur L.,Lee Brendan

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.1998.9.11-1587

Reference65 articles.

1. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.

2. Characterization of an Adenovirus Gene Transfer Vector Containing an E4 Deletion

3. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors

4. Eight ‘Musts’ for Biotechnology

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adenoviral Gene Therapy Vectors in Clinical Use—Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety;International Journal of Molecular Sciences;2023-11-20

2. Adenovirus as a Vector and Oncolytic Virus;Current Issues in Molecular Biology;2023-06-02

3. Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19;SN Comprehensive Clinical Medicine;2021-06-22

4. Helper virus-free gutless adenovirus (HF-GLAd): a new platform for gene therapy;BMB Reports;2020-11-30

5. Gene Therapy in Retinal Dystrophies;International Journal of Molecular Sciences;2019-11-14